Visceral adipose tissue

There are 155 papers on visceral adipose tissue in aging research: 29 trials and 108 observational studies in people, 1 in animals, 16 reviews. The newest story, Oct 30, 2026: “Muscle fat linked to death risk in metabolic fatty liver disease”.

Biomarker

155 papers study it564 more mention it69 findings

42 new papers in 30 daysSee all 719 papers on visceral adipose tissue

At a glance

Visceral adipose tissue is associated with frailty in men in human observational studies; a human study also links it with greater PhenoAge acceleration. Human cohorts link it with higher risks of type 2 diabetes, cardiovascular events, and chronic kidney disease. A study finds no clear cardiovascular disease link after adjustment for BMI and waist circumference; mortality associations vary across populations.

69 findings in 47 papers from 2010 to 2026, 13 of them since June 2026

“Single-slice VAT showed strong associations with incident T2D (HR 1.82, 95% CI 1.57-2.11)”
Associations between MRI-Derived Visceral Adipose Tissue and Incident Cardiometabolic Outcomes in a Large Population CohortADA Scientific Sessions 2026 abstract2026doi:10.2337/db26-2621-p
  • Human trial29
  • Humans108
  • Animals1

Interventions

10

Longevity medicine programme

downin humans1

1 study
  1. Longevity medicine programme is linked with lower visceral adipose tissue in humans (paired comparison of baseline and follow-up assessments, uncontrolled).

    Humanspaired comparison of baseline and follow-up assessments, uncontrolledvisceral adipose tissuen = 1,122

More on Longevity medicine programme

Poverty

no changein humans1

1 study
  1. Poverty was not clearly linked with visceral adipose tissue in humans (childhood).

    Humanschildhood

More on Poverty

Bariatric surgery

downin humans1

1 study
  1. Bariatric surgery is linked with lower visceral adipose tissue in humans (longitudinal post-MBS follow-up to 89 months) (R2 = 0.661, p < 0.001).

    Humanslongitudinal post-MBS follow-up to 89 monthsup to 89 monthsn = 39

More on Bariatric surgery

SGLT2 inhibitors

downin humans1

1 study
  1. SGLT2 inhibitors decrease visceral adipose tissue in humans (-0.66 [-1.22 to -0.10]).

    Reviewvisceral adipose tissuemean 29.4 weeksn = 2,741

More on SGLT2 inhibitors

GLP-1 receptor agonists

downin humans1

1 study
  1. GLP-1 receptor agonists decrease visceral adipose tissue in humans (-0.90 [-1.32 to -0.47]).

    Reviewvisceral adipose tissuemean 29.4 weeksn = 2,741

More on GLP-1 receptor agonists

Exercise

no changein humans1

1 study
  1. Exercise showed no clear effect on visceral adipose tissue in humans.

    Human trialcycling16 consecutive daysmalesn = 5

More on Exercise

Socioeconomic disadvantage

upin humans1OR 2.5

1 study
  1. Socioeconomic disadvantage is linked with higher visceral adipose tissue in humans (comparing most disadvantaged group (ADI > 80) to least disadvantaged group (ADI < 20)) (OR = 2.5, p < .001).

    Humanscomparing most disadvantaged group (ADI > 80) to least disadvantaged group (ADI < 20)n = 7,644

More on Socioeconomic disadvantage

We

no changein humans1

1 study
  1. We showed no clear effect on visceral adipose tissue in humans (compared with wait-list control) (P = 0.5).

    Human trialcompared with wait-list controlvisceral adipose tissue10 weeks

More on We

Fish oil

no changein humans1

1 study
  1. Fish oil showed no clear effect on visceral adipose tissue in humans (p > 0.05).

    Human trial1728 mg marine triglycerides, of which 588 mg EPA and 412 mg DHA, combined with 200 mg antioxidant, coenzyme Q1012 weeksmalesn = 50

More on Fish oil

Tesamorelin

downin humans1−15%

1 study
  1. Tesamorelin decreases visceral adipose tissue in humans (-15.4%).

    Human trialsc dailyvisceral adipose tissue2 mg26 wkn = 806

More on Tesamorelin

Effects

8

Distant metastasis-free survival

no changein humans1

1 study
  1. Visceral adipose tissue was not clearly linked with distant metastasis-free survival in post-mastectomy BC patients.

    Humansin post-mastectomy BC patients

Precuneus volume

no changein humans1

1 study
  1. Visceral adipose tissue was not clearly linked with precuneus volume in type 2 diabetes mellitus with highest quartile of visceral adipose tissue (p = .54).

    Humansin type 2 diabetes mellitus with highest quartile of visceral adipose tissueprecuneusn = 144

More on Precuneus volume

Posterior cingulate gyrus volume

downin humans1

1 study
  1. Visceral adipose tissue is linked with lower posterior cingulate gyrus volume in type 2 diabetes mellitus with highest quartile of visceral adipose tissue (F=336.9, p = .000013).

    Humansin type 2 diabetes mellitus with highest quartile of visceral adipose tissueposterior cingulate gyrusn = 144

More on Posterior cingulate gyrus volume

Hippocampal volume

downin humans1

1 study
  1. Visceral adipose tissue is linked with lower hippocampal volume in type 2 diabetes mellitus with highest quartile of visceral adipose tissue (F=376.2, p = .012).

    Humansin type 2 diabetes mellitus with highest quartile of visceral adipose tissuehippocampusn = 144

More on Hippocampal volume

Brain parenchymal volume

downin humans1

1 study
  1. Visceral adipose tissue is linked with lower brain parenchymal volume in type 2 diabetes mellitus with highest quartile of visceral adipose tissue (F=632, p <.0001).

    Humansin type 2 diabetes mellitus with highest quartile of visceral adipose tissuebrainn = 144

More on Brain parenchymal volume

Cardiovascular disease

no changein humans1

1 study
  1. Visceral adipose tissue was not clearly linked with cardiovascular disease in humans (adjusted for BMI and waist circumference).

    Humansadjusted for BMI and waist circumferencemedian of 7.9 yearsn = 4,866

More on Cardiovascular disease

Mortality

no changein humans1HR 1.002

1 study
  1. Visceral adipose tissue was not clearly linked with mortality in humans (pre-TAVR) (HR 1.002, 95% CI: 0.99-1.015; p = 0.7).

    Humanspre-TAVR5-yearn = 500

Global cognitive function

no changein humans1

1 study
  1. Visceral adipose tissue was not clearly linked with global cognitive function in humans (β = -0.03 (-0.07, 0.02)).

    Humansn = 652

Upstream

2

Age

upin humans1

1 study
  1. Age is linked with higher visceral adipose tissue in humans (healthy Brazilian adults).

    Humanshealthy Brazilian adultsn = 1,621

Body mass index

no changein humans1

1 study
  1. Body mass index was not clearly linked with visceral adipose tissue in humans (patients with BMI >= 35 kg/m2) (r = 0.10, p = 0.37).

    Humanspatients with BMI >= 35 kg/m2

More on Body mass index

Associations

42

Mortality

upin humans2HR 1.07

2 studies
  1. Visceral adipose tissue is associated with mortality in humans (Association attenuated after adjustment for BMI).

    HumansAssociation attenuated after adjustment for BMIvisceral adipose tissuePer 1-SD increase in visceral adipose tissueMedian follow-up of 5.1 yearsn = 11,914

  2. Visceral adipose tissue is associated with mortality in humans (non-CRC-related mortality in stage I-III CRC patients) (HR 1.07, 95% CI 1.01-1.14).

    Humansnon-CRC-related mortality in stage I-III CRC patientsadipose tissuemedian follow-up of 5.0 yearsn = 402

    Muscle, fat not tied to relapse after stage I–III bowel cancer surgery

    Surgical oncology

Carotid-femoral pulse wave velocity

upin humans2

2 studies
  1. Visceral adipose tissue predicts carotid-femoral pulse wave velocity in humans (Apparently healthy postmenopausal East Asian women; age-adjusted analysis).

    HumansApparently healthy postmenopausal East Asian women; age-adjusted analysisfemalesn = 118

  2. Visceral adipose tissue predicts carotid-femoral pulse wave velocity in humans (pre- and postmenopausal Asian women) (p<0.001).

    Humanspre- and postmenopausal Asian womenfemales

More on Carotid-femoral pulse wave velocity

Type 2 diabetes

upin humans2HR 1.82

2 studies
  1. Visceral adipose tissue is linked with a higher risk of type 2 diabetes in humans (HR 1.82, 95% CI 1.57-2.11).

    Humansn = 75,331

  2. Visceral adipose tissue predicts type 2 diabetes in humans (multivariable-adjusted) (HR up to 2.69).

    Humansmultivariable-adjustedn = 66,608

More on Type 2 diabetes

Breast cancer

upin humans2OR 1.003

2 studies
  1. Visceral adipose tissue is linked with a higher risk of breast cancer in humans (adjusted for menopause status, comorbidities, laboratory indices, and lifestyle factors) (OR=1.003, 95%: 1.0005~1.005).

    Humansadjusted for menopause status, comorbidities, laboratory indices, and lifestyle factors

  2. Visceral adipose tissue is associated with breast cancer in humans (postmenopausal women; third versus first tertile) (Third versus first tertile aHR 1.24, 95% CI 1.10–1.45).

    Humanspostmenopausal women; third versus first tertilevisceral adipose tissuefemalesn = 15,669

More on Breast cancer

Frailty

upin humans2

2 studies
  1. Visceral adipose tissue is associated with frailty in humans (β = 0.008, 95% CI, 0.0005-0.02, P = .04).

    Humansadjusted for age, race, ethnicity, duration between imaging and eFI measurements, and imaging parametersvisceral adipose tissuemalesn = 437

  2. Visceral adipose tissue is associated with frailty in humans (aOR 4.45).

    Humansmalesn = 399

Metabolic syndrome

upin humans1OR 1.41

1 study
  1. Visceral adipose tissue predicts metabolic syndrome in humans (cutoff 642.5 g) (AUC = 0.740, cutoff 642.5 g).

    Humanscutoff 642.5 gmales

  2. Visceral adipose tissue is associated with metabolic syndrome in humans (per each 100 g increase, adjusted for confounders) (OR 1.41, 95% CI 1.15-1.72).

    Humansper each 100 g increase, adjusted for confoundersmales

More on Metabolic syndrome

Risk of malnutrition

upin humans1OR 1.46

1 study
  1. Visceral adipose tissue is associated with risk of malnutrition in humans (Adjusted for age and sex; association attenuated after adjustment for depressive symptoms) (OR 1.46 per kg, 95% CI 1.02 to 2.10).

    HumansAdjusted for age and sex; association attenuated after adjustment for depressive symptomsvisceral adipose tissuen = 388

Cardiovascular mortality

upin humans1

1 study
  1. Visceral adipose tissue is associated with cardiovascular mortality in humans.

    Humansvisceral adipose tissuePer 1-SD increase in visceral adipose tissueMedian follow-up of 5.1 yearsn = 11,914

Prevalent atherosclerotic cardiovascular disease

upin humans1

1 study
  1. Visceral adipose tissue is associated with prevalent atherosclerotic cardiovascular disease in humans.

    Humansvisceral adipose tissuePer 1-SD increase in visceral adipose tissuen = 11,914

More on Prevalent atherosclerotic cardiovascular disease

TyG-WC

upin humans1

1 study
  1. TyG-WC is associated with visceral adipose tissue in humans.

    Humansn = 821

More on TyG-WC

All 42

Funding

3 grants since 2018

National Heart, Lung, and Blood Institute$854KNational Institute of Diabetes and Digestive and Kidney Diseases$172KEuropean Foundation for the Study of Diabetes

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human data associate visceral adipose tissue with cardiometabolic conditions after BMI adjustment. A human preprint links it to fatty liver and TyG-WC; another reports no effect of childhood poverty on visceral adipose tissue.

  2. Summary written from the findings.

Latest

Dec 2025: 22Jan 2026: 27Feb 2026: 25Mar 2026: 28Apr 2026: 7May 2026: 12Jun 2026: 16Jul 2026: 19Aug 2026: 18Sep 2026: 16Oct 2026: 31Nov 2026: 19240 papers in 12 months
Diagnostics

Muscle fat linked to death risk in metabolic fatty liver disease

In 10,490 UK Biobank adults with metabolic fatty liver disease, an observational analysis linked muscle fat to death and brain blood vessel disease.In 10,490 UK Biobank adults with metabolic fatty liver disease, an observational analysis linked muscle fat to death and brain blood vessel disease.

Cohort · 10,490 peopleBiomarkers
ESC Congress 2026 Abstract

Body fat and muscle patterns are linked to type 2 diabetes risk

Compared with a healthy group, the hazard ratio for type 2 diabetes was 3.43 for visceral obesity and 4.92 for sarcopenic obesity.Compared with a healthy group, the hazard ratio for type 2 diabetes was 3.43 for visceral obesity and 4.92 for sarcopenic obesity.

Cohort · 8,208 peopleType 2 diabetes
ESC Congress 2026 Abstract

Fat around the heart is linked to higher heart disease risk

In 61,336 adults, greater heart fat was associated with 17 percent higher coronary heart disease risk and 20 percent higher risk of atrial fibrillation.In 61,336 adults, greater heart fat was associated with 17 percent higher coronary heart disease risk and 20 percent higher risk of atrial fibrillation.

Cohort · 61,336 peopleBiomarkers

See all 719 papers on visceral adipose tissue